Lung cancer claims thousands of lives annually Learn the risks warning signs and steps you can take to protect yourself and your loved ones.
"Tumor-active T cells are very important to a patient's response to therapy, but they are difficult to ... to identify these ...
Dr Zaheer Mangera discusses the evolution of the neoadjuvant lung cancer pathway and notable changes to the TNM standards.
Lung cancer treatment and outcomes are profoundly influenced by the tumor microenvironment (TME), particularly in resectable ...
Though smoking and increasing levels of pollution exposure are well recognised as causes of lung cancer the connection ...
A new artificial intelligence model has demonstrated high accuracy in detecting and outlining lung tumors on CT scans, ...
clinicaltrialsarena on MSN7d
MAIA’s lung cancer therapy 99% more likely to improve OS over chemo aloneIn the Phase II MAIA lung cancer trial, THIO improved patients’ overall survival when taken in combination with Libtayo.
A recent study found that structured cessation programs improve quit rates among lung cancer screening participants. How can physicians leverage this?
Researchers have developed a computer model to help scientists identify tumor-fighting immune cells in patients with lung cancer treated with immune checkpoint inhibitors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback